comparemela.com

Nikhil C. Munshi, MD, discusses potential future directions for ciltacabtagene autoleucel and other CAR T-cell therapies in patients with multiple myeloma.

Related Keywords

Nikhilc Munshi , ,Harvard Medical School ,Jerome Lipper Multiple Myeloma Center ,Dana Farber Cancer Institute ,Correlative Science ,Kraft Family Chair ,Multiple Myeloma Immune Effector Cell Therapy ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.